Hospital Network Antwerp / Ziekenhuis Netwerk Antwerpen (ZNA)

Screening and diagnostic breast MRI: how do they impact surgical treatment? Insights from the MIPA study (2023) Cozzi A, Di Leo G, Houssami N, Gilbert FJ, Helbich TH, Álvarez Benito M, Balleyguier C, et al. Journal article Impaired B Cell Expression of the Inhibitory Fcγ Receptor IIB in Myasthenia Gravis (2022) Keller CW, Chuquisana O, Derdelinckx J, Gross CC, Berger K, Robinson J, Nimmerjahn F, et al. Journal article Biopsy Sampling in Upper Gastrointestinal Endoscopy: A Survey from 10 Tertiary Referral Centres across Europe (2021) Bornschein J, Tran-Nguyen T, Fernandez-Esparrach G, Ash S, Balaguer F, Bird-Lieberman EL, Córdova H, et al. Journal article Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma (2021) Dighe SG, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, Levine DM, et al. Journal article Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020) Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al. Journal article New Technologies and Applications in Sacral Neuromodulation: An Update (2020) De Wachter S, Knowles CH, Elterman DS, Kennelly MJ, Lehur PA, Matzel K, Engelberg S, Van Kerrebroeck PE Journal article European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions (2020) Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, et al. Journal article Programming Algorithms for Sacral Neuromodulation: Clinical Practice and Evidence—Recommendations for Day-to-Day Practice (2020) Lehur PA, Sørensen M, Dudding TC, Knowles CH, de Wachter S, Engelberg S, Matzel KE Journal article, Review article Quantitative radionuclide imaging of bone metastases (2019) De Schepper S, Ritt P, Van den Wyngaert T, Kuwert T Journal article A phase II randomized study of neoadjuvant letrozole plus alpelisib for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (NeO-ORB) (2019) Mayer IA, Prat A, Egle D, Blau S, Alejandro Perez Fidalgo J, Gnant M, Fasching P, et al. Journal article